XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue - Disaggregation (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues disaggregated by Group        
Total revenue $ 742.8 $ 638.9 $ 2,110.0 $ 1,822.3
Revenue recognized at a point in time        
Revenues disaggregated by Group        
Total revenue 643.1 557.0 1,828.5 1,580.2
Revenue recognized over time        
Revenues disaggregated by Group        
Total revenue 99.7 81.9 281.5 242.1
United States        
Revenues disaggregated by Group        
Total revenue 211.1 191.8 565.5 518.3
Germany        
Revenues disaggregated by Group        
Total revenue 78.0 51.9 202.1 177.7
Rest of Europe        
Revenues disaggregated by Group        
Total revenue 174.0 151.7 495.0 425.4
CHINA        
Revenues disaggregated by Group        
Total revenue 136.7 111.6 360.8 291.0
Rest of Asia Pacific        
Revenues disaggregated by Group        
Total revenue 92.6 85.1 332.0 271.1
Other        
Revenues disaggregated by Group        
Total revenue 50.4 46.8 154.6 138.8
Operating segments | Bruker BioSpin        
Revenues disaggregated by Group        
Total revenue 198.3 175.7 540.6 493.3
Operating segments | Bruker CALID        
Revenues disaggregated by Group        
Total revenue 239.3 207.5 703.2 601.0
Operating segments | Bruker NANO        
Revenues disaggregated by Group        
Total revenue 238.7 199.1 673.4 559.8
Operating segments | BEST        
Revenues disaggregated by Group        
Total revenue 70.6 59.3 205.5 178.2
Eliminations        
Revenues disaggregated by Group        
Total revenue [1] $ (4.1) $ (2.7) $ (12.7) $ (10.0)
[1] Represents corporate costs and eliminations not allocated to the reportable segments.